<abstract xmlns="http://www.w3.org/1999/xhtml">

<sec id="j_raon-2023-0010_s_005"><h3>Background</h3>
<p>Electrochemotherapy has good local effectiveness in the treatment of vulvar cancer. Most studies have reported the safety and effectiveness of electrochemotherapy for palliative treatment of gynecological cancers and mostly vulvar squamous cell carcinoma. Some tumors, however, fail to respond to electrochemotherapy. The biological features/determinants for the nonresponsiveness are not determined yet.</p></sec>
<sec id="j_raon-2023-0010_s_006"><h3>Patient and methods</h3>
<p>A recurrence of vulvar squamous cell carcinoma was treated by electrochemotherapy using intravenous administration of bleomycin. The treatment was performed by hexagonal electrodes according to standard operating procedures. We analyzed the factors that could determine nonresponsiveness to electrochemotherapy.</p></sec>
<sec id="j_raon-2023-0010_s_007"><h3>Results</h3>
<p>Based on the presented case of nonresponsive vulvar recurrence to electrochemotherapy, we hypothesize that the vasculature of the tumors prior to treatment may predict the response to electrochemotherapy. The histological analysis showed minimal presence of blood vessels in the tumor. Thus, low perfusion may reduce drug delivery and lead to a lower response rate because of the minor antitumor effectiveness of vascular disruption. In this case, no immune response in the tumor was elicited by electrochemotherapy.</p></sec>
<sec id="j_raon-2023-0010_s_008"><h3>Conclusions</h3>
<p>In this case, of nonresponsive vulvar recurrence treated by electrochemotherapy, we analyzed possible factors that could predict treatment failure. Based on histological analysis, low vascularization of the tumor was observed, which hampered drug delivery and distribution and resulted in no vascular disrupting action of electro-chemotherapy. All these factors could contribute to ineffective treatment with electrochemotherapy.</p></sec>
</abstract>

Background
Electrochemotherapy has good local effectiveness in the treatment of vulvar cancer. Most studies have reported the safety and effectiveness of electrochemotherapy for palliative treatment of gynecological cancers and mostly vulvar squamous cell carcinoma. Some tumors, however, fail to respond to electrochemotherapy. The biological features/determinants for the nonresponsiveness are not determined yet.
Patient and methods
A recurrence of vulvar squamous cell carcinoma was treated by electrochemotherapy using intravenous administration of bleomycin. The treatment was performed by hexagonal electrodes according to standard operating procedures. We analyzed the factors that could determine nonresponsiveness to electrochemotherapy.
Results
Based on the presented case of nonresponsive vulvar recurrence to electrochemotherapy, we hypothesize that the vasculature of the tumors prior to treatment may predict the response to electrochemotherapy. The histological analysis showed minimal presence of blood vessels in the tumor. Thus, low perfusion may reduce drug delivery and lead to a lower response rate because of the minor antitumor effectiveness of vascular disruption. In this case, no immune response in the tumor was elicited by electrochemotherapy.
Conclusions
In this case, of nonresponsive vulvar recurrence treated by electrochemotherapy, we analyzed possible factors that could predict treatment failure. Based on histological analysis, low vascularization of the tumor was observed, which hampered drug delivery and distribution and resulted in no vascular disrupting action of electro-chemotherapy. All these factors could contribute to ineffective treatment with electrochemotherapy.

Treatment of vulvar cancer recurrences with electrochemotherapy – a detailed analysis of possible causes for unsuccessful treatment

Radiology and Oncology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Background
Electrochemotherapy has good local effectiveness in the treatment of vulvar cancer. Most studies have reported the safety and effectiveness of...

First author, year published	Included no. of patients	Average age	Histology	Response of vulvar cancer
First author, year published	Included no. of patients	Average age	Histology	OR	NR
Perrone, 2013²⁰	8	84y	8 SCC	6/8 (75%)	2/8 (25%)
Perrone, 2015²¹	25	85y	25 SCC	20/25 (80%)	5/20 (20%)
Pellegrino, 2016¹⁸	10	68y	1 9 Paget’s SCC	6/10 (60%)	4/10 (40%)
Perrone, 2019¹³	55	79y	57 SCC 3 Paget’s 1 melanoma	46/55 (84%)	9/55 (16%)
Corrado, 2020¹⁶	15	83y	14 1 SCC CS	12/15 (80%)	3/15 (20%)

Treatment of vulvar cancer recurrences with electrochemotherapy – a detailed analysis of possible causes for unsuccessful treatment

Article Category: Research Article

Data publikacji: 17 lut 2023

Zakres stron: 121 - 126

Otrzymano: 21 gru 2022

Przyjęty: 11 sty 2023

DOI: https://doi.org/10.2478/raon-2023-0010

© 2023 Gregor Vivod, Tanja Jesenko, Gorana Gasljevic, Nina Kovacevic, Masa Bosnjak, Gregor Sersa, Sebastjan Merlo, Maja Cemazar, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1

Figure 2

Figure 3

Review of studies evaluating electrochemotherapy in vulvar cancer